These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1605452)

  • 41. Microbial contamination and growth in total parenteral nutrition solutions.
    Lawrence J; Turner M; Gilbert P
    J Clin Pharm Ther; 1988 Apr; 13(2):151-7. PubMed ID: 3134366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Control of the biological contamination index in total parenteral nutrition (TPN) preparations].
    Llor Ferrández B; Hernández Sansalvador M; Gómez-Juárez F
    Nutr Hosp; 1993 Feb; 8(2):115-9. PubMed ID: 8466994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Practical aspects of multichamber bags for total parenteral nutrition.
    Mühlebach S
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):291-5. PubMed ID: 15809532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preparation of intravenous hyperalimentation solution].
    Terada A; Koakutsu H; Tanaka H; Sakaue I; Yurino Y; Yamamoto M; Tanaka Y
    Nihon Rinsho; 1991 Nov; 49 Suppl():147-54. PubMed ID: 1798084
    [No Abstract]   [Full Text] [Related]  

  • 45. Frequency of intravenous administration set changes and bacteremia: defining the risk.
    Graeber BD
    Infect Control Hosp Epidemiol; 2001 Aug; 22(8):476. PubMed ID: 11700870
    [No Abstract]   [Full Text] [Related]  

  • 46. A new apparatus for chronic intravenous infusion in unrestrained rats.
    Takeyama H; Yura J; Miyaike H; Ishikawa M; Mizuno H; Taniguchi M; Hanai T; Mizuno A; Shinagawa N; Kato F
    JPEN J Parenter Enteral Nutr; 1988; 12(1):93-9. PubMed ID: 3125365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particulate and microbial contamination in in-use admixed parenteral nutrition solutions.
    Oie S; Kamiya A
    Biol Pharm Bull; 2005 Dec; 28(12):2268-70. PubMed ID: 16327163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin A sorption to polyvinyl and polyolefin intravenous tubing.
    Henton DH; Merritt RJ
    JPEN J Parenter Enteral Nutr; 1990; 14(1):79-81. PubMed ID: 2109120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence and clinical significance of intravenous fat emulsion contamination during infusion.
    Ebbert ML; Farraj M; Hwang LT
    JPEN J Parenter Enteral Nutr; 1987; 11(1):42-5. PubMed ID: 3102780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Control over the bacteriological quality of preparations for TPN by the sequential sampling technic].
    Alférez García I; Socías Manzano MS
    Nutr Hosp; 1992; 7(6):400-10. PubMed ID: 1477151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface characterisation of bags for total parenteral nutrition by tensiometry and atomic force microscopy.
    Realdon N; Zennaro L; Perin F; Bettero A; Bortoluzzi S; Rigo A; Ragazzi E
    Int J Pharm; 2003 Oct; 265(1-2):27-35. PubMed ID: 14522115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A bag carrier for continuous intravenous hyperalimentation.
    Haraguchi M; Arinaga S; Sakata T; Ueo H; Nakashima H; Shibuta K; Mori M; Akiyoshi T
    Nutrition; 1997 Jun; 13(6):554-6. PubMed ID: 9263237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a prototype air-venting inline intravenous filter set.
    Rapp R; Bivins B; Schroeder H; DeLuca PP
    Am J Hosp Pharm; 1975 Dec; 32(12):1253-9. PubMed ID: 813522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid Detection of Microbial Contamination in Intravenous Fluids by ATP-Based Monitoring System.
    Oie S; Kamiya A; Yamasaki H; Kouda K; Furukawa H; Tsuruta R
    Jpn J Infect Dis; 2020 Sep; 73(5):363-365. PubMed ID: 32350221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations in aseptic techniques during preparation and administration of intravenous drugs-an observation-based study in the UK and in Germany.
    Taxis K; Wirtz V; Barber N
    J Hosp Infect; 2004 Jan; 56(1):79-81. PubMed ID: 14706281
    [No Abstract]   [Full Text] [Related]  

  • 56. Blastoschizomyces capitatus infection after contamination of fluids for intravenous application.
    Mathews MS; Sen S
    Mycoses; 1998 Nov; 41(9-10):427-8. PubMed ID: 9916469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Further confirmation that spiking of intravenous bags does not cause time-dependent microbial contamination.
    Segal S
    Infect Control Hosp Epidemiol; 2019 Jan; 40(1):111-112. PubMed ID: 30394236
    [No Abstract]   [Full Text] [Related]  

  • 58. Spiking of intravenous bags does not cause time-dependent microbial contamination: a preliminary report.
    Brock-Utne JG; Smith SC; Banaei N; Chang SC; Alejandro-Harper D; Jaffe RA
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1129-1130. PubMed ID: 29961441
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitative determination of particulate contamination in intravenous administration sets.
    Di Paolo ER; Hirschi B; Pannatier A
    Pharm Weekbl Sci; 1990 Oct; 12(5):190-5. PubMed ID: 2255588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barrier technology for TPN compounding; advantages and limitations.
    Lee MG
    Nutrition; 1997 Mar; 13(3):245-6. PubMed ID: 9131694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.